Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Diluted EPS of $0.55 per share (loss) for fiscal year 2025.
ASSEMBLY BIOSCIENCES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.55 | +91.8% |
| 2024 | -$6.69 | +50.0% |
| 2023 | -$13.38 | +42.0% |
| 2022 | -$23.08 | -669.3% |
| 2021 | -$3.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.72 | +52.3% | +45.9% |
| June 30, 2025 | -$1.33 | +32.8% | -13.7% |
| March 31, 2025 | -$1.17 | +29.5% | +22.5% |
| September 30, 2024 | -$1.51 | +54.1% | +23.7% |
| June 30, 2024 | -$1.98 | +49.0% | -19.3% |
| March 31, 2024 | -$1.66 | +62.8% | +49.5% |
| September 30, 2023 | -$3.29 | -585.4% | +15.2% |
| June 30, 2023 | -$3.88 | -660.8% | +13.0% |
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +91.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, ASSEMBLY BIOSCIENCES, INC.’s diluted eps has grown by 81.7% (from $3.00 per share (loss) to $0.55 per share (loss)).
- The most recent figure is from ASSEMBLY BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: